Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. ABBV
4. MU
5. META
6. SPY
7. ACN
8. BLZE
9. IBM
10. NKE

Go back to Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

Medtronic, Inc. (MDT) PT Raised to $93 at Oppenheimer Following 4Q

May 26, 2017 9:52 AM EDT

Oppenheimer raised its price target on Medtronic, Inc. (NYSE: MDT) to $93.00 (from $87.00) while maintaining a Outperform rating. MDT beat 4Q EPS by $0.02, led by higher constant-currency sales and gross margin along with lower FX headwind to EPS, somewhat offset by higher interest... More

Medtronic, Inc. (MDT) PT Raised to $94 at Barclays; Reiterates Overweight

May 26, 2017 7:59 AM EDT

Barclays raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $92.00) while maintaining a Overweight... More